Racecadotril

DB11696InvestigationalSmall molecule

Racecadotril is an anti-secretory enkephalinase inhibitor useful in the treatment of diarrhea. Racecadotril has been investigated for the basic science and treatment of Diarrhea, Acute Diarrhea, and Acute Gastroenteritis.

Mechanism: Pharmacologically active on Neprilysin
Curator reviewed
Formula / weight: C₂₁H₂₃NO₄S · 385.48 g/mol (avg)

Resolves to

Compound

UNII76K53XP4TOCAS81110-73-8ChEMBLCHEMBL2103772ChEBI91508PubChem107751

Clinical / RWD

RxNorm16738ATCA07XA04

Structure

InChIKeyODUOJXZPIYUATO-UHFFFAOYSA-NSMILESCC(=O)SCC(CC1=CC=CC=C1)C(=O)NCC(=O)OCC1=CC=CC=C1

Targets

P08473MME

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

13Clinical trialsPhase, status and sponsor resolved per trial

4Structured indicationsCondition, population, route and combination as fields, not prose

1ContraindicationEach with its own population and attribute set

64Marketed productsAcross 8 countries and 19 labellers

1ATC codeIncluding every combination product, plus 12 drug categories

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Racecadotril, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account